Feasibility of Simplification From a Basal-Bolus Insulin Regimen to a Fixed-Ratio Formulation of Basal Insulin Plus a GLP-1RA or to Basal Insulin Plus an SGLT2 Inhibitor: BEYOND, a Randomized, Pragmatic Trial

MLA

Maria Ida Maiorino, et al. “Feasibility of Simplification From a Basal-Bolus Insulin Regimen to a Fixed-Ratio Formulation of Basal Insulin Plus a GLP-1RA or to Basal Insulin Plus an SGLT2 Inhibitor: BEYOND, a Randomized, Pragmatic Trial.” Diabetes Care, vol. 44, no. 6, Apr. 2021, pp. 1353–60. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....1928bce38e65f8eb35666f88c7cc7b16&authtype=sso&custid=ns315887.

APA

Maria Ida Maiorino, Rosa Di Fraia, Paola Caruso, Miriam Longo, Lorenzo Scappaticcio, Michela Petrizzo, Maurizio Gicchino, Katherine Esposito, Giuseppe Bellastella, & Dario Giugliano. (2021). Feasibility of Simplification From a Basal-Bolus Insulin Regimen to a Fixed-Ratio Formulation of Basal Insulin Plus a GLP-1RA or to Basal Insulin Plus an SGLT2 Inhibitor: BEYOND, a Randomized, Pragmatic Trial. Diabetes Care, 44(6), 1353–1360.

Chicago

Maria Ida Maiorino, Rosa Di Fraia, Paola Caruso, Miriam Longo, Lorenzo Scappaticcio, Michela Petrizzo, Maurizio Gicchino, Katherine Esposito, Giuseppe Bellastella, and Dario Giugliano. 2021. “Feasibility of Simplification From a Basal-Bolus Insulin Regimen to a Fixed-Ratio Formulation of Basal Insulin Plus a GLP-1RA or to Basal Insulin Plus an SGLT2 Inhibitor: BEYOND, a Randomized, Pragmatic Trial.” Diabetes Care 44 (6): 1353–60. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....1928bce38e65f8eb35666f88c7cc7b16&authtype=sso&custid=ns315887.